• Profile
Close

Influences of breakfast on clock gene expression and postprandial glycemia in healthy individuals and individuals with diabetes: A randomized clinical trial

Diabetes Care Aug 31, 2017

Jakubowicz D, et al. – A randomized clinical trial was designed to explore the acute effect of breakfast consumption or omission on glucose homeostasis and clock gene expression in healthy individuals and individuals with type 2 diabetes. The obtained data demonstrate that breakfast consumption acutely affects clock and clock–controlled gene expression leading to normal oscillation. Moreover, breakfast skipping adversely affects clock and clock–controlled gene expression and is associated with increased postprandial glycemic response in both healthy individuals and individuals with diabetes.

Methods
  • In a cross-over design, researchers randomized18 healthy volunteers and 18 volunteers with 14.5 ± 1.5 years diabetes, BMI 30.7 ± 1.1 kg/m2, and HbA1c 7.6 ± 0.1% (59.6 ± 0.8 mmol/mol) to a test day with breakfast and lunch (YesB) and a test day with only lunch (NoB).
  • They evaluated postprandial clock and clock-controlled gene expression, plasma glucose, insulin, intact glucagon-like peptide-1 (iGLP-1), and dipeptidyl peptidase IV (DPP-IV) plasma activity after breakfast and lunch.

Results
  • The expression level of Per1, Cry1, Ror α, and Sirt1 was lower (P < 0.05) but Clock was higher (P < 0.05) after breakfast in healthy individuals.
  • On the other hand, in individuals with type 2 diabetes, Per1, Per2, and Sirt1 only slightly, but significantly, decreased and Ror α increased (P < 0.05) after breakfast. In healthy individuals, the expression level of Bmal1, Ror α, and Sirt1 was higher (P < 0.05) after lunch on YesB day, whereas the other clock genes remained unchanged.
  • The data showed that Bmal1, Per1, Per2, Rev-erb α, and Ampk increased (P < 0.05) after lunch on the YesB day in individuals with type 2 diabetes.
  • Remarkably, omission of breakfast altered clock and metabolic gene expression in both healthy and individuals with type 2 diabetes.
Go to Original
Only Doctors with an M3 India account can read this article. Sign up for free or login with your existing account.
4 reasons why Doctors love M3 India
  • Exclusive Write-ups & Webinars by KOLs

  • Nonloggedininfinity icon
    Daily Quiz by specialty
  • Nonloggedinlock icon
    Paid Market Research Surveys
  • Case discussions, News & Journals' summaries
Sign-up / Log In
x
M3 app logo
Choose easy access to M3 India from your mobile!


M3 instruc arrow
Add M3 India to your Home screen
Tap  Chrome menu  and select "Add to Home screen" to pin the M3 India App to your Home screen
Okay